GSEA of MaP−/− mammary tumors compared with MaPR245W/− tumors demonstrated enrichment for the IFNγ response and IFNα response pathways (FDR < 0.05; Supplementary Table S5; refs. 46, 64). The gene discussed is IFNG; the disease is breast cancer.